NICE approves Lenvima for differentiated thyroid cancer
NICE has issued its final appraisal decision recommending reimbursement of…
NICE has issued its final appraisal decision recommending reimbursement of Lenvima for the treatment of progressive, locally advanced or metastatic, differentiated thyroid carcinoma...